- Financial Times•1 hour ago
The heads of GE, Boeing and other corporate heavyweights have warned that the US may not have another opportunity to revamp its tax code for 30 years if it misses out on a chance to do it now amid uproar ...
- Investopedia•21 hours ago
Celgene’s multiple sclerosis drug ozanimod beat rival Avonex in a Phase 3 study.
- Motley Fool•23 hours ago
Healthcare bargains abound for patient long-term investors.
CELG : Summary for Celgene Corporation - Yahoo Finance
Celgene Corporation (CELG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||121.01 x 100|
|Ask||122.40 x 100|
|Day's Range||118.81 - 121.19|
|52 Week Range||94.39 - 127.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||48.64|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|